ArticleOncotarget2011

Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects.

Taolin Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.